Skip to main content

Peer Review reports

From: Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells

Original Submission
2 Oct 2020 Submitted Original manuscript
21 Oct 2020 Author responded Author comments - Fumihiko Matsuzawa
Resubmission - Version 2
21 Oct 2020 Submitted Manuscript version 2
6 Nov 2020 Reviewed Reviewer Report
13 Nov 2020 Reviewed Reviewer Report
15 Nov 2020 Reviewed Reviewer Report
27 Nov 2020 Author responded Author comments - Fumihiko Matsuzawa
Resubmission - Version 3
27 Nov 2020 Submitted Manuscript version 3
30 Nov 2020 Reviewed Reviewer Report
2 Dec 2020 Reviewed Reviewer Report
3 Dec 2020 Reviewed Reviewer Report
7 Dec 2020 Author responded Author comments - Fumihiko Matsuzawa
Resubmission - Version 4
7 Dec 2020 Submitted Manuscript version 4
Publishing
9 Dec 2020 Editorially accepted
26 Feb 2021 Article published 10.1186/s12885-020-07722-3

You can find further information about peer review here.

Back to article page